Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:1208-1215

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, D.
Right arrow Articles by Fukuuchi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, D.
Right arrow Articles by Fukuuchi, Y.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Acute Cerebral Infarction
Right arrow Pathology of Stroke

(Stroke. 2001;32:1208.)
© 2001 American Heart Association, Inc.


Original Contributions

Enhanced Expression of Iba1, Ionized Calcium-Binding Adapter Molecule 1, After Transient Focal Cerebral Ischemia In Rat Brain

Daisuke Ito, MD; Kortaro Tanaka, MD; Shigeaki Suzuki, MD; Tomohisa Dembo, MD Yasuo Fukuuchi, MD

From the Department of Neurology, School of Medicine, Keio University, Tokyo, Japan.

Correspondence to Daisuke Ito, MD, Department of Neurology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail di49{at}med.keio.ac.jp

Background and Purpose—Iba1 is a novel calcium-binding protein and is specifically expressed in microglia in the brain. It has been suggested that Iba1 plays an important role in regulation of the function of microglia. In the present study we examined time-dependent Iba1 expression after transient middle cerebral artery occlusion and characterized microglial activation in various brain regions.

Methods—Rat middle cerebral artery occlusion was induced by the intraluminal filament technique. After 1.5 hours of transient ischemia, Iba1 expression was examined by immunohistochemical and immunoblot analyses. The microglial activation in association with ischemic severity was characterized by double immunostaining with other specific markers.

Results—In the peri-ischemic area, heavily Iba1 immunoreactive cells rapidly appeared at 3.5 hours after reperfusion. Immunoreactivity was further increased and peaked at 7 days. In the ischemic core, round Iba1-positive cells, which may be blood-borne monocytes, appeared from 24 hours and reached a peak at 4 to 7 days. Double immunostaining revealed that activated microglia in the peri-ischemic area upregulated Iba1 expression but were negative for the macrophage marker ED1. ED1-positive cells were clearly restricted to the ischemic core.

Conclusions—These findings suggest the following: (1) Iba1 expression may be associated with microglial activation in ischemic brain, and Iba1 immunostaining can be useful to evaluate the pathophysiological roles of activated microglia in ischemic injury. (2) Expression of ED1 antigen is strictly restricted to severe ischemic damage, whereas activated microglia in the peri-ischemic area showed Iba1 upregulation without ED1. Therefore, microglia may exhibit difference of antigenicity in the severity of ischemic brain injury.


Key Words: gene expression • ischemia • macrophages • microglia • middle cerebral artery occlusion • stroke, ischemic




This article has been cited by other articles:


Home page
IOVSHome page
C. S. Chen, M. A. Johnson, R. A. Flower, B. J. Slater, N. R. Miller, and S. L. Bernstein
A Primate Model of Nonarteritic Anterior Ischemic Optic Neuropathy
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2985 - 2992.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. S. El-Amouri, H. Zhu, J. Yu, R. Marr, I. M. Verma, and M. S. Kindy
Neprilysin: An Enzyme Candidate to Slow the Progression of Alzheimer's Disease
Am. J. Pathol., May 1, 2008; 172(5): 1342 - 1354.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Z. Ahmed, G. Shaw, V. P. Sharma, C. Yang, E. McGowan, and D. W. Dickson
Actin-binding Proteins Coronin-1a and IBA-1 Are Effective Microglial Markers for Immunohistochemistry
J. Histochem. Cytochem., July 1, 2007; 55(7): 687 - 700.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. C. Zerrate, M. Pletnikov, S. L. Connors, D. L. Vargas, F. J. Seidler, A. W. Zimmerman, T. A. Slotkin, and C. A. Pardo
Neuroinflammation and Behavioral Abnormalities after Neonatal Terbutaline Treatment in Rats: Implications for Autism
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 16 - 22.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. Wang and S. Dore
Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage
Brain, June 1, 2007; 130(6): 1643 - 1652.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Saraswathy, G. Wu, and N. A. Rao
Retinal microglial activation and chemotaxis by docosahexaenoic Acid hydroperoxide.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3656 - 3663.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Kitaoka, Y. Kitaoka, J. M. K. Kwong, F. N. Ross-Cisneros, J. Wang, R. K. Tsai, A. A. Sadun, and T. T. Lam
TNF-{alpha}-Induced Optic Nerve Degeneration and Nuclear Factor-{kappa}B p65.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1448 - 1457.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. J. Barber, D. A. Antonetti, T. S. Kern, C. E. N. Reiter, R. S. Soans, J. K. Krady, S. W. Levison, T. W. Gardner, and S. K. Bronson
The Ins2Akita Mouse as a Model of Early Retinal Complications in Diabetes
Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2210 - 2218.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Ito, J. R. Walker, C. S. Thompson, I. Moroz, W. Lin, M. L. Veselits, A. M. Hakim, A. A. Fienberg, and G. Thinakaran
Characterization of Stanniocalcin 2, a Novel Target of the Mammalian Unfolded Protein Response with Cytoprotective Properties
Mol. Cell. Biol., November 1, 2004; 24(21): 9456 - 9469.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Harada, C. Harada, S. Kohsaka, E. Wada, K. Yoshida, S. Ohno, H. Mamada, K. Tanaka, L. F. Parada, and K. Wada
Microglia-Muller Glia Cell Interactions Control Neurotrophic Factor Production during Light-Induced Retinal Degeneration
J. Neurosci., November 1, 2002; 22(21): 9228 - 9236.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. Naskar, M. Wissing, and S. Thanos
Detection of Early Neuron Degeneration and Accompanying Microglial Responses in the Retina of a Rat Model of Glaucoma
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2962 - 2968.
[Abstract] [Full Text] [PDF]